Stay updated on Tolebrutinib in NRSPMS Clinical Trial
Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, signaling a small update to the page's underlying content or structure.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.5.3 now appears on the page, replacing Revision: v3.5.2. This reflects a small, non-substantive update to the page’s documentation/version tag rather than any change to study data, eligibility criteria, or results.SummaryDifference0.0%

- Check35 days agoChange DetectedLocation entries for Gurgaon, India were adjusted for consistent spelling (diacritic removed), leaving the rest of the study details unchanged.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated to v3.5.2. The previous v3.5.0 entry was removed.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Gūrgaon, India, 122001 and 122002 as site entries with macronized spelling and removed the corresponding plain Gurgaon entries (122001 and 122002); Revision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check72 days agoChange DetectedStandardized the India locations by replacing the diacritic spelling Gūrgaon with Gurgaon for site IDs 122001 and 122002.SummaryDifference0.0%

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.